Background: Gas chromatographic documentation of volatile sulfur compounds in Helicobacter pylori cultures and the amelioration of halitosis after eradication suggested a causal link between H. pylori infection and halitosis. Aim: We hypothesized that Korea red ginseng can relieve H. pylori-associated halitosis based on their anti-inflammatory and cytoprotective actions in H. pylori-associated gastritis. Methods: Eighty-eight functional dyspepsia patients presenting with either subjective halitosis or objective halimeter levels >100 ppb were recruited, on whom tests were repeated after 10 weeks of red ginseng administration. The expressions of cystathionine γ-lyase (CSE), cystathionine β-synthetase (CBS), IL-6, IL-8 and IL-1β mRNA were compared in H. pylori-infected or NaHS-treated gastric epithelial cells according to red ginseng treatment. Results: After 10 weeks of red ginseng administration, 38 patients out of 68 H. pylori-positive cases became ‘free of halitosis’ accompanied with halimeter levels <50 ppb accordant with the subjective resolution of halitosis. Among the remaining 30 patients, 15 cases administered with both eradication regimen and red ginseng supplement showed either higher eradication rates (93.3%) or were found to be completely free of halitosis in comparison to the other 15 patients who were only administered the eradication regimen. Among 20 H. pylori-negative patients, 13 patients became ‘free of halitosis’ with 10 weeks of red ginseng treatment alone. Red ginseng extracts significantly decreased H. pylori- or NaHS-induced CSE expressions concomitant with attenuated levels of IL-6, IL-8 and IL-1β mRNA. Conclusion: The strategy consisting of Korea red ginseng supplementation after the successful eradication of H. pylori could be an effective way to fight troublesome halitosis.

1.
Porter SR, Scully C: Oral malodour (halitosis). BMJ 2006;333:632&ndash;635.
[PubMed]
2.
Tangerman A: Halitosis in medicine: a review. Int Dental J 2002;52:201&ndash;206.
[PubMed]
3.
Feller L, Blignaut E: Halitosis: a review. SADJ 2005;60:17&ndash;19.
[PubMed]
4.
Donaldson AC, Riggio MP, Rolph HJ, Bagg J, Hodge PJ: Clinical examination of subjects with halitosis. Oral Dis 2007;13:63&ndash;70.
[PubMed]
5.
Hoshi K, Yamano Y, Mitsunaga A, Shimizu S, Kagawa J, Ogiuchi H: Gastrointestinal diseases and halitosis: association of gastric Helicobacter pylori infection. Int Dent J 2002;52:207&ndash;211.
[PubMed]
6.
Lee H, Kho HS, Chung JW, Chung JW, Chung SC, Kim YK: Volatile sulfur compounds produced by Helicobacter pylori. J Clin Gastroenterol 2006;40:421&ndash;426.
[PubMed]
7.
Tiomny E, Arber N, Moshkowitz M, Peled Y, Gilat T: Halitosis and Helicobacter pylori. A possible link? J Clin Gastroenterol 1992;15:236&ndash;237.
[PubMed]
8.
Ierardi E, Amoruso A, Lanotte T, et al: Halitosis and Helicobacter pylori: a possible relationship. Dig Dis Sci 1998;43:2733&ndash;2737.
[PubMed]
9.
Katsinelos P, Tziomalos K, Chatzimavroudis G, et al: Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome. Med Princ Pract 2007;16:119&ndash;123.
[PubMed]
10.
Park S, Yeo M, Jin JH, et al: Rescue of Helicobacter pylori-induced cytotoxicity of red ginseng. Dig Dis Sci 2005;52:1218&ndash;1227.
11.
Park S, Yeo M, Jin JH, et al: Inhibitory activities and attenuated expressions of 5-LOX with red ginseng in Helicobacter pylori-infected gastric epithelial cells. Dig Dis Sci 2007;52:973&ndash;982.
[PubMed]
12.
Pratibna PK, Bhat KM, Bhat GS: Oral malodor: a review of the literature. J Dent Hyg 2006;80:8.
13.
Yoo SH, Jung HS, Sohn WS, et al: Volatile sulfur compounds as a predictor for esophagogastroduodenal mucosal injury. Gut Liver 2008;2:113&ndash;118.
14.
Lowicka E, Beltowsi J: Hydrogen sulfide (H2S) &ndash; the third gas of interest for pharmacologists. Pharmacol Reports 2007;59:4&ndash;24.
[PubMed]
15.
Lee EH, Hahm KB, Lee JH, Park JJ, Kim DH, Kim SK, Choi SR, Lee ST: Development and validation of a functional dyspepsia-related quality of life (FD-QOL) scale in South Korea. J Gastroenterol Hepatol2006;21:268&ndash;274.
[PubMed]
16.
Kim DK, Lee JA, Kim YB, Lee KM, Hahm KB: A randomized controlled trial assessing Korea red ginseng treatment of Helicobacter pylori-associated chronic gastritis. Kor J Med 2007;72:20&ndash;28.
17.
Tamizhselvi R, Moore PK, Bhatia M: Hydrogen sulfide acts as a mediator of inflammation in acute pancreatitis: in vitro studies using isolated mouse pancreatic acinar cells. J Cell Mol Med 2007;11:315&ndash;326.
[PubMed]
18.
Serin E, Gumurdulu Y, Kayaselcuk F, Ozer B, Yilmaz U, Boyacioglu S: Halitosis in patients with Helicobacter pylori-positive non-ulcer dyspepsia: an indication for eradication therapy? Eur J Int Med 2003;14:45&ndash;48.
[PubMed]
19.
Schicho R, Krueger D, Zeller F, et al: Hydrogen sulfide is a novel prosecretory neuromodulator in the guinea pig and human colon. Gastroenterology 2006;131:1542&ndash;1552.
[PubMed]
20.
Mok YY, Atan MS, Yole Ping C, et al: Role of hydrogen sulfide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol 2004;143:881&ndash;889.
[PubMed]
21.
Adler I, Denninghoff VC, Alvarez MI, Avagnina A, Yoshida R, Elsner B. Helicobacter pylori associated with glossitis and halitosis. Helicobacter 2005;10:312&ndash;317.
[PubMed]
22.
Moshkowitz M, Horowitz N, Leshno M, Halpern Z: Halitosis and gastroesophageal reflux disease: a possible association. Oral Dis 2007;13:581&ndash;585.
[PubMed]
23.
Sopapornamorn P, Ueno M, Shinada K, Yanagishita M, Kawaguchi Y: Relationship between total salivary protein content and volatile sulfur compounds levels in malodor patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:655&ndash;660.
[PubMed]
24.
Washio J, Sato T, Koseki T, Takahashi N: Hydrogen sulfide-producing bacteria in tongue biofilm and their relationship with oral malodour. J Med Microbiol 2005;54:889&ndash;895.
[PubMed]
25.
Krespi YP, Shrime MG, Kacker A: The relationship between oral malodor and volatile sulfur compound-producing bacteria. Otolaryngol Head Neck Surg 2006;135:671&ndash;676.
[PubMed]
26.
Suzuki H, Marshall BJ, Hibi T: Overview: Helicobacter pylori and extragastric diseases. Int J Hematol 2006;84:291&ndash;300.
[PubMed]
27.
Suzuki H, Hibi T, Marshall BJ: Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol 2007;42:1&ndash;15.
[PubMed]
You do not currently have access to this content.